Lenz K, Dieplinger B, Buder R, Piringer P, Rauch M, Voglmayr M
Internal and Intensive Care Medicine, Konventhospital Barmherzige Brüder, Linz.
Central Laboratory, Konventhospital Barmherzige Brüder, Linz.
Z Gastroenterol. 2014 Oct;52(10):1175-7. doi: 10.1055/s-0034-1385171. Epub 2014 Oct 14.
In a 63-year-old cirrhotic patient, recanalisation of a partial portal vein thrombosis was achieved by a low dose of rivaroxaban (10 mg daily). After anticoagulant therapy was stopped, partial vein thrombosis recurred. Restarting rivaroxaban at a dose of 10 mg led to recanalisation. The patient did not suffer any complications; in particular no bleeding occurred during 8 months of treatment.
在一名63岁的肝硬化患者中，低剂量利伐沙班（每日10毫克）实现了部分门静脉血栓的再通。抗凝治疗停止后，部分静脉血栓复发。重新以10毫克的剂量使用利伐沙班导致血栓再通。患者未出现任何并发症；特别是在8个月的治疗期间未发生出血。
